NCT04522557View on ClinicalTrials.gov

Type I Interferon Alfa-2a in Postmastectomy Breast Reconstruction

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 6, 2020

Primary Completion Date

July 14, 2021

Study Completion Date

July 14, 2021

Conditions
Breast Neoplasms
Interventions
DRUG

IFNα-2a

After mastectomy, it is used in the cavity of breast before conducting implantation.

Trial Locations (1)

510120

Shicheng Su, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

NCT04522557 - Type I Interferon Alfa-2a in Postmastectomy Breast Reconstruction | Biotech Hunter | Biotech Hunter